Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline

OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Brain Behav
Hoofdauteurs: Eliassen, Carl F., Reinvang, Ivar, Selnes, Per, Grambaite, Ramune, Fladby, Tormod, Hessen, Erik
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/
https://ncbi.nlm.nih.gov/pubmed/28948074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items